(Date:5/16/2008)...ulti-center registry presented at conference, NAT...n Scientific,Corporation (NYSE: BSX ) today annou...ter patient registry documenting the safety and cl...tion System will be presented at,Digestive Disease...iego,CA. Registry results will be announced in th...
(Date:5/16/2008)...Company,s partner Aqua Bounty to scale back ...gram - TSX symbol: SBS,...ys Genetics Inc.,(TSX:SBS), a biotechnology compan...or metabolic and cardiovascular diseases, today an...ImmunoSphere(TM) shrimp feed additive,program, Aqu...
(Date:5/16/2008)...6 /- Highlighting the,compa...rrent product,pipeline, Michael V. Novinski, Presi...aq: EMIS ), was featured in an extensive intervie... (TWST). Established more than 40,years ago, TWST ...ding,CEOs, analysts and money managers, and publis...
(Date:5/16/2008)...wire/ -- Alba Therapeutics Corporation,announced t... patient in a,twelve-week Phase IIb trial with ora...arrier dysfunction, for the treatment of patients ...center, randomized, double-blind,placebo-controll...al,efficacy, safety and tolerability of larazotide...
Breaking Biology Technology:Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 2Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 3Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 4Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 5SemBioSys provides update on shrimp feed additive, Immunosphere(TM) 2SemBioSys provides update on shrimp feed additive, Immunosphere(TM) 3Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript 2Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript 3Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 2Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 3...on Cassettes , siRNA expres...pportunities to study gene silencing. Unfortunatel...ectors is labor and time intensive. , ...ssion , Cassette Kits provide a... siRNA expression cassettes (SECs) that ca...
...ption Kit For One Step qRT-PCR , ... II and other RNase H MMLV reverse transcri...argets , over a 106-fold range , ... as 500 fg total RNA 1/20th of a single cell! ... complete in 15 min , ,...
...d cell sorting (FACS) is a , tool for mea...rties of , individual cells using fluores..., associated with the cell. This technology... given population down to the level of a single ce...ation from 1-1000 Cells. , Dr. Daniel Dou...
...malian RNA from , complex mixtures of...procedure takes less than 2 hours , ... Seamless integration with , MICR..., Enables microarray expression an...from host cells , Ambion,s new ,...
Other Biology Technology:GENE SILENCING WITH PCR PRODUCTS 2GENE SILENCING WITH PCR PRODUCTS 3GENE SILENCING WITH PCR PRODUCTS 4GENE SILENCING WITH PCR PRODUCTS 5GENE SILENCING WITH PCR PRODUCTS 6GENE SILENCING WITH PCR PRODUCTS 7GENE SILENCING WITH PCR PRODUCTS 8HIGH SENSITIVITY qRT-PCR 2HIGH SENSITIVITY qRT-PCR 3HIGH SENSITIVITY qRT-PCR 4HIGH SENSITIVITY qRT-PCR 5Cells-to-cDNA II Using FACS Sorted Cells 2Bacterial RNA Isolation From Infected Eukaryotic Hosts 2Bacterial RNA Isolation From Infected Eukaryotic Hosts 3Bacterial RNA Isolation From Infected Eukaryotic Hosts 4Bacterial RNA Isolation From Infected Eukaryotic Hosts 5Bacterial RNA Isolation From Infected Eukaryotic Hosts 6(Date:5/15/2008)...he human race was divided into two separate groups...e, says a Tel Aviv University mathematician. Clima...itions may have caused and maintained the separati...thematical Sciences at Tel Aviv University, worked...cal Center to analyze African DNA. Their goal was ...
(Date:5/15/2008)..., Ill. (May 15, 2008) Argonne National Laboratory...th Savannah River National Laboratory (SRNL) to co...gement research projects in support of critical U....nt national priorities. , "The MOU allows Argonn...Argonne director Robert Rosner said. "Argonne has ...
(Date:5/15/2008)... Institute researchers Karen Staehling-Hampton, Ph...livier Pourqui, Ph.D., Investigator, collaborated ... genes known to cause spinal mutations in chick an...in human patients with congenital vertebral abnorm... the Web site of the American Journal of Human Gen...
(Date:5/15/2008)... business practice usually reserved for boosting p...ucing their energy use? Writing in the Internation...(IJSSCA), researchers in India provide an answer. ...shik of NC College of Engineering in Haryana, Indi...t the forefront of company efforts. In a global ec...
Breaking Biology News(10 mins):Long lost sisters 2Argonne-SRNL agreement supports critical DOE, national priorities 2Stowers Institute researchers identify gene linked to vertebral defects in patient populations 2Adding up business and energy 2CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego 1284 1CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego 1284 2CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego 1284 3CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego 1284 4Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 1Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 2Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 3Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 4Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 5IASP declares the Global Year Against Pain in Women 3775 1IASP declares the Global Year Against Pain in Women 3775 2IASP declares the Global Year Against Pain in Women 3775 3UD named a regional research participant in National Children 26 23146 3Bs Study 819 1UD named a regional research participant in National Children 26 23146 3Bs Study 819 2Mouse polyclonal antibody raised against a partial recombinant XAGE2. Immunogen: XAGE2 (NP_570133, 44 a.a. ~ 112 a.a) partial recombinant protein with GST tag. Accession Number: NM_130777
...urate Results Laser Capture Microdissection (LCM)...ity and accuracy of molecular assays by starting w...llular structures isolated from whole tissue or cy...ction-developed in 1996 at the National Institutes...
Mouse polyclonal antibody raised against a partial recombinant ZFHX4. Immunogen: ZFHX4 (NP_078997, 2 a.a. ~ 94 a.a) partial recombinant protein with GST tag. Accession Number: NM_024721 Pr
EPA II Buffer is a diluent formulated to stabilize the activity of Chemicon horseradish peroxidase (HRP)-antibody conjugates at high conjugate dilution for extended periods.
Biology Products: